Most Active Biotech Investors in South San Francisco 2026
15 firms writing Biotech checks in South San Francisco, led by AME Cloud Ventures, Breakout Ventures.
Biotech in South San Francisco accounts for 15 tracked companies with verified cap-table data, 15 of which disclose round sizes totalling $3.4B. The median disclosed raise is $200M, and the largest is ORIC Pharmaceuticals at $900M, ahead of Alumis ($529M) and Terremoto Biosciences ($250M).
The names that recur most often on these biotech cap tables are Alexandria Venture Investments (5 companies), Eli Lilly and Company (4 companies), Janus Henderson Investors (3 companies), EcoR1 Capital (2 companies), Foresite Capital (2 companies), venBio Partners (2 companies). By latest disclosed round, the market skews Series B (5), Series A (4), Series D (3), IPO (1).
Companies tracked: 15
Disclosed funding total: $3.4B across 15 companies
Median disclosed raise: $200M
Largest raise: ORIC Pharmaceuticals — $900M
Stage mix: Series B 5 · Series A 4 · Series D 3 · IPO 1
Most recent dated round: 2026-06-10
Best funded Biotech in South San Francisco companies
